1. Home
  2. LIXT vs NYC Comparison

LIXT vs NYC Comparison

Compare LIXT & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$7.00

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo American Strategic Investment Co.

NYC

American Strategic Investment Co.

HOLD

Current Price

$8.26

Market Cap

24.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
NYC
Founded
2005
2013
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
24.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
LIXT
NYC
Price
$7.00
$8.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
140.9K
27.2K
Earning Date
05-08-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
85.28
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$56.73
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$7.03
52 Week High
$7.50
$16.30

Technical Indicators

Market Signals
Indicator
LIXT
NYC
Relative Strength Index (RSI) 67.55 43.75
Support Level $2.92 $7.84
Resistance Level N/A $8.63
Average True Range (ATR) 0.82 0.84
MACD 0.07 -0.15
Stochastic Oscillator 82.94 1.34

Price Performance

Historical Comparison
LIXT
NYC

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Share on Social Networks: